A detailed history of Oregon Public Employees Retirement Fund transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 25,338 shares of ARWR stock, worth $533,364. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,338
Previous 25,838 1.94%
Holding current value
$533,364
Previous $671,000 26.97%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$19.36 - $29.54 $9,680 - $14,770
-500 Reduced 1.94%
25,338 $490,000
Q2 2024

Aug 01, 2024

SELL
$21.87 - $28.24 $104,976 - $135,552
-4,800 Reduced 15.67%
25,838 $671,000
Q1 2024

May 02, 2024

BUY
$27.21 - $39.48 $8,979 - $13,028
330 Added 1.09%
30,638 $876,000
Q4 2023

Feb 12, 2024

BUY
$21.2 - $31.03 $4,240 - $6,206
200 Added 0.66%
30,308 $927,000
Q3 2023

Oct 26, 2023

SELL
$26.2 - $36.08 $20,960 - $28,864
-800 Reduced 2.59%
30,108 $809,000
Q2 2023

Jul 26, 2023

SELL
$25.16 - $41.38 $17,612 - $28,966
-700 Reduced 2.21%
30,908 $1.1 Million
Q1 2023

May 04, 2023

BUY
$23.68 - $38.51 $10,135 - $16,482
428 Added 1.37%
31,608 $802,000
Q4 2022

Jan 26, 2023

BUY
$28.0 - $40.56 $9,212 - $13,344
329 Added 1.07%
31,180 $0
Q2 2022

Jul 25, 2022

SELL
$27.79 - $50.61 $68,613 - $124,956
-2,469 Reduced 7.41%
30,851 $1.09 Million
Q1 2022

Apr 21, 2022

SELL
$39.62 - $69.97 $31,695 - $55,976
-800 Reduced 2.34%
33,320 $1.53 Million
Q4 2021

Feb 01, 2022

SELL
$58.09 - $82.51 $57,276 - $81,354
-986 Reduced 2.81%
34,120 $2.26 Million
Q3 2021

Oct 19, 2021

SELL
$58.38 - $84.96 $17,922 - $26,082
-307 Reduced 0.87%
35,106 $2.19 Million
Q2 2021

Jul 23, 2021

BUY
$62.15 - $90.32 $77,998 - $113,351
1,255 Added 3.67%
35,413 $2.93 Million
Q1 2021

Apr 20, 2021

BUY
$61.35 - $90.47 $13,803 - $20,355
225 Added 0.66%
34,158 $2.27 Million
Q4 2020

Feb 09, 2021

SELL
$43.82 - $85.37 $29,666 - $57,795
-677 Reduced 1.96%
33,933 $2.6 Million
Q3 2020

Nov 03, 2020

SELL
$33.21 - $51.27 $84,619 - $130,635
-2,548 Reduced 6.86%
34,610 $1.49 Million
Q2 2020

Jul 21, 2020

SELL
$26.12 - $43.27 $13,060 - $21,635
-500 Reduced 1.33%
37,158 $1.61 Million
Q1 2020

Apr 20, 2020

SELL
$20.56 - $63.12 $5,695 - $17,484
-277 Reduced 0.73%
37,658 $1.08 Million
Q4 2019

Feb 05, 2020

BUY
$28.14 - $73.01 $6,612 - $17,157
235 Added 0.62%
37,935 $2.41 Million
Q3 2019

Nov 07, 2019

BUY
$26.26 - $34.86 $971,620 - $1.29 Million
37,000 Added 5285.71%
37,700 $1.06 Million
Q2 2019

Jul 16, 2019

BUY
$17.43 - $28.82 $12,201 - $20,174
700 New
700 $19,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.